Ignyta (RXDX) Tops Q2 EPS by 10c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Ignyta (RXDX) Tops Q2 EPS by 10c

Ignyta Announces Second Quarter 2015 Company Highlights and Financial Results

August 10, 2015 4:00 PM EDT

SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (Nasdaq: RXDX), a precision oncology biotechnology company, today announced company highlights and financial results for the second quarter ended June 30, 2015.

Since the beginning of the second quarter of 2015, we have continued to make important strides toward our goal of becoming a leading precision oncology biotechnology company that can provide compelling treatment options to cancer patients with unmet needs, said Jonathan Lim, M.D., Chairman and CEO of Ignyta. We made strong progress on our lead product candidate, entrectinib, announcing promising data at ASCO from our two Phase... More